Neurizon Therapeutics Reports Positive NUZ-001 Study
Neurizon Therapeutics (ASX: NUZ) has announced encouraging outcomes from an independent study assessing its neuroprotective ...
Small Caps1d
Neurizon Therapeutics reports positive study results on human brain model by neuroprotective candidate NUZ-001
Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...
Stockhead on MSN1d
StockTake: Neurizon’s potential cure for Alzheimer’s
NUZ-001 has shown it promotes healthy and viable brain tissues, potentially demonstrating its use to treat Alzheimer’s and ...
HotCopper on MSN1d
Neurizon finds positive results for lead drug in 3D brain model study
Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...
StockTake: Neurizon’s lead asset shows positive results in latest study
Neurizon Therapeutics' (ASX:NUZ) lead drug candidate has demonstrated positive results in the latest round of testing with ...
Stockhead1d
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.
ALS News Today4d
NUZ-001 slows decline in ALS lung function, Phase 1 trial shows
NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...